Clinical Trial Update: Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial update on the safety and clinical use of the Fentanyl Transdermal System for cancer-related pain, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cancer Pain

Drugs mentioned

• Fentanyl Transdermal System (fentanyl)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED